Additionally, a more recent study showed reduced circulating OPG together with reduced mRNA and serum levels of RANKL in NAFLD patients compared to healthy controls [94]. This evidence concerns the gene TNFRSF11B and metabolic dysfunction-associated steatotic liver disease.